System and method for the personalisation and optimization of anti-cancer treatments
WO2014060443A2
A composite scaffold for use as a tissue engineering implant
GB201318081D0
Bone spreader/compressor
CN104220433A
Process for the preparation of gamma amino acids and intermediates used in the process
CA2852811A1
Adam22 for use as a prognostic variable, and target for therapy, of a metastatic breast cancer disease
CA2850258A1
Inhibition of microrna-134 for the treatment of seizure-related disorders and neurologic injuries
WO2013001002A1
A computer-implemented system and method for the prediction of cancer response to genotoxic chemotherapy and personalised neoadjuvant treatments (pccp)
EP2660746A1
Dose-response medical outcome model predictor system and method
EP2691525A1
Treatment and prognosis of solid tumour cancers
EP2604265A1
P2x7 antagonists as frontline or adjunctive treatment against status epilepticus
EP2581447A1
Selective isolation of a messenger RNA molecule having its cognate micro RNA molecules bound thereto
WO2010109019A1
Orodispersible tablets
US2010251438A1
Microscopy control system and method
EP2255813A1
Derivatives of ursodeoxycholic acid for the treatment of diarrhoea
EP2253306A1
Orodispersible dosage forms containing solid drug dispersions
WO2009144690A1
A method of assessing cancer status in a breast cancer patient
EP2196456A1
A method for preparing sulfur-containing compounds
EP2195658A2
A method of assessing colorectal cancer status in an individual
EP2153833A1
ADP-receptor antagonist for treatment of inflammatory disease
